The nation's top infectious disease expert says some 28 million children ages 5 to 11 in the United States may be able to receive their Covid-19 vaccine in the first two weeks of November.
Search / 504 results found Showing: 1-10 of 504
BEAVERTON, Ore. (KPTV) - After receiving approval by the FDA, a panel for the CDC is now also endorsing Moderna and Johnson & Johnson boos…
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday.
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
The US will donate more than 17 million doses of the Johnson & Johnson COVID-19 vaccine to the African Union.
Vaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose …
COVID-19 deaths and hospitalizations are expected to decline over the next fours weeks, according to ensemble forecasts from the US Centers for Disease Control and Prevention published Wednesday.
The US Preventive Services Task Force posted a draft statement recommending that adults ages 40 to 59 who are at a higher risk for cardiovascu…
The US Preventive Services Task Force is considering making several changes to its guidance on taking a daily aspirin to prevent heart disease and stroke.
Pfizer said Thursday it's asked the US Food and Drug Administration to authorize use of a low-dose version of its Covid-19 vaccine for children 5 to 11.